Jonathan Malz was Appointed as Vice President, Ethics and Compliance Officer at DBV Technologies

Date of management change: September 10, 2019 

What Happened?

New York, NY-based DBV Technologies Appointed Jonathan Malz as Vice President, Ethics and Compliance Officer


About the Company

DBV Technologies (DBV) is a clinical-stage biopharmaceutical company focused on discovering safe and effective treatments for patients with food allergies and other unmet medical needs. DBV has developed a proprietary technology platform called Viaskin®, which is based on epicutaneous immunotherapy, or EPIT®, DBV`s method of delivering biologically active compounds to the immune system. This novel mechanism of action accesses the immune system through intact skin without allowing passage of the antigen into the bloodstream. The company is also exploring Viaskin® in other areas of unmet need including vaccines, inflammatory conditions and autoimmune diseases. DBV was founded in 2002 by Dr. Pierre-Henri Benhamou, Chairman and CEO, Dr. Christophe Dupont, Chairman of DBV`s Scientific Advisory Board, and Mr. Bertrand Dupont, Chief Technology Officer.


About the Person

Jonathan Malz is Vice President, Ethics and Compliance Officer at DBV Technologies. Previously, Jonathan held various senior legal leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Tyler Tan, Martin Susan, Badger Zoe, Kaufman Jules, Stone Alex, Beaudouin Mark, McNally Daniel, Dour Fred, Lynch Condy, Rosasco Robert, Masten Dale

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.